Title
Interleukin-15 activates human natural killer cells to clear the intestinal protozoan Cryptosporidium
Date Issued
01 September 2005
Access level
open access
Resource Type
journal article
Author(s)
Dann S.M.
Wang H.C.
Gambarin K.J.
Actor J.K.
Robinson P.
Lewis D.E.
Caillat-Zucman S.
Baylor College of Medicine
Abstract
Intracellular protozoans of the genus Cryptosporidium are a major cause of diarrheal illness worldwide, but little is known about the mechanisms that control intestinal infection. We have previously demonstrated interleukin (IL)-15 expression in the intestinal mucosa of seronegative symptomatic volunteers after oral challenge with C. parvum, which suggests a role for IL-15 in the control of acute infection. We hypothesize that IL-15 activates an innate cytolytic cell response that contributes to the clearance of initial C. parvum infection. We report here that IL-15 activates peripheral blood mononuclear cells to lyse Cryptosporidium-infected epithelial cells in a dose-dependent manner. Lysis was due to CD3-CD16+CD56+ cells (i.e., natural killer [NK] cells). Furthermore, flow cytometry revealed that IL-15 increased expression of the activation receptor NKG2D on NK cells, particularly among the CD16Hi cytolytically active cells. Major histocompatibility complex class I-related molecules A and B (MICA and MICB), ligands for NKG2D, were increased after infection of epithelial cell lines and human ileal tissue. These data suggest that IL-15 has an important role in activating an NK cell-mediated pathway that leads to the elimination of intracellular protozoans from the intestines, which is a previously unrecognized feature of NK cell function. © 2005 by the Infectious Diseases Society of America. All rights reserved.
Start page
1294
End page
1302
Volume
192
Issue
7
Language
English
OCDE Knowledge area
Parasitología Inmunología
Scopus EID
2-s2.0-25444486729
PubMed ID
Source
Journal of Infectious Diseases
ISSN of the container
00221899
Sponsor(s)
Received 1 February 2005; accepted 28 April 2005; electronically published 23 August 2005. Presented in part: Experimental Biology 2004 meeting: “Translating the Genome,” Washington, DC, 17–21 April 2004; 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, September 30–October 3, 2004. Potential conflicts of interest: none reported. Financial support: National Institutes of Health (grant RO1 AI4173); Baylor Center for AIDS Research (grant AI36211). a These authors contributed equally to this study. Reprints or correspondence: Dr. A. Clinton White, Jr., Dept. of Medicine–Infectious Diseases, Baylor College of Medicine, One Baylor Plaza, 535EA, Houston, TX 77030 (arthurw@bcm.tmc.edu).
Sources of information: Directorio de Producción Científica Scopus